logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
I

Ildiko Lingvay

University of Texas Southwestern Medical Center

86H指数
442论文数
4.2W被引数
收录论文 193
发表时间
logo
B cell mechanisms underlie IgG glycan alterations in obesity肥胖下B细胞机制导致IgG糖基改变
errGlycobiology
IF3.3
err2026-08-29
err0
errOAAI
errJun Peng; Ming Yang; Anika Mijakovac; Ken L Chambliss; Md Nurul Islam; Tamara Štambuk; Domagoj Kifer; Kenian Chen; Iwona Borošak; Helena Deriš; Kristina Nikolić Prpić; Nancy Monson; Ildiko Lingvay; Olga T Gupta; Vlatka Zoldoš; Gordan Lauc; Jacob Hartz; Lin Xu; Chieko Mineo; Philip W Shaul; null
err分享
err收藏
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial出版更正：在超重或肥胖人群中口服小分子GLP-1受体激动剂阿尼利普龙的研究：一项随机、双盲、安慰剂对照的2b期临床试验
errNature Medicine
IF50
err2026-06-24
err0
errOAAI
errJulio Rosenstock; Ildiko Lingvay; Donna Ryan; Ania M. Jastreboff; Robert Kushner; Andres Acosta; Thomas C. Blevins; Melissa Choi; Faith L. Holmes; Timothy Smith; Lisa Connery; Yao Li; Mike Ke Liu; Aline Barth; Jamie Butcher; Antonio Civitarese; Huibin Yue; Blai Coll
err分享
err收藏
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial口服小分子GLP-1受体激动剂阿利吉隆在超重或肥胖人群中的研究：一项随机、双盲、安慰剂对照的2b期临床试验
errNature Medicine
IF50
err2026-06-05
err0
errOAAI
errJulio Rosenstock; Ildiko Lingvay; Donna Ryan; Ania M. Jastreboff; Robert Kushner; Andres Acosta; Thomas C. Blevins; Melissa Choi; Faith L. Holmes; Timothy Smith; Lisa Connery; Yao Li; Mike Ke Liu; Aline Barth; Jamie Butcher; Antonio Civitarese; Huibin Yue; Blai Coll
err分享
err收藏
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines设计下一代肥胖药物的心血管代谢结局试验
errJACC
IF0
err2026-04-21
err0
PREAI
errElke Platz; Alexander Peikert; Biykem Bozkurt; Bart Van der Schueren; Javed Butler; Ildiko Lingvay; Darren K. McGuire; Faiez Zannad; Naveed Sattar
err分享
err收藏
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome醛固酮增多症在心血管-肾脏-代谢综合征的病理生理及管理中的作用
errdiabetes, obesity and metabolism
IF0
err2026-04-20
err0
errOAAI
errEvan Zeitler; Klara R. Klein; Ildiko Lingvay; Anthony Pick; Liana K. Billings
err分享
err收藏
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trialSemaglutide对高危肝纤维化患者的肝纤维化和心脏结局的影响: 一项选择性随机试验的预设分析
errNature Medicine
IF50
err2026-04-02
err0
errOAAI
errSebastian M. Meyhöfer; Bertrand Cariou; Cintia Cercato; Helen M. Colhoun; John Deanfield; Michelle T. Long; Ole Kleist Jeppesen; A. Michael Lincoff; Ildiko Lingvay; Jorge Plutzky; Philip N. Newsome; Stephen J. Nicholls; Maria Quiroga; Ferruccio Santini; Arun J. Sanyal; Steven E. Kahn
err分享
err收藏
Comparing survey delivery methods in healthcare: A randomized study比较医疗保健中的调查交付方法：一项随机研究
errJournal of Clinical and Translational Science
IF2
err2025-11-17
err0
errOAAI
errTumyan, Gayane; Esselink, Kathleen; Navar, Ann Marie; Lingvay, Ildiko
err分享
err收藏
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial司美格鲁肽和心血管结局与基线及体脂测量值变化的关系：SELECT试验的预先指定分析
errThe Lancet
IF97.3
err2025-10-22
err0
errOAAI
errJohn Deanfield; A Michael Lincoff; Steven E Kahn; Scott S Emerson; Ildiko Lingvay; Benjamin M Scirica; Jorge Plutzky; Robert F Kushner; Helen M Colhoun; G Kees Hovingh; Signe Stensen; Peter E Weeke; Ole Kleist Jeppesen; Rafael Bravo; Chau-Chung Wu; Issei Komuro; Ferruccio Santini; Jøran Hjelmesæth; Miguel Urina-Triana; Silvio Buscemi; Donna H Ryan
err分享
err收藏
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or ObesityWharton S, Lingvay I, Bogdanski P, Duque do Vale R, Jacob S, Karlsson T, et al. Semaglutide在25 mg剂量下用于超重或肥胖成人的研究。新英格兰医学杂志（2025）393:1077–87。doi: 10.1056/NEJMoa2500969
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-09-18
err4
PREAI
errWharton, Sean; Lingvay, Ildiko; Bogdanski, Pawel; Duque do Vale, Ruben; Jacob, Stephan; Karlsson, Tobias; Shaji, Chaithra; Rubino, Domenica; Garvey, W. Timothy
err分享
err收藏
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial每周一次司美格鲁肽7.2 mg在肥胖成人中的疗效研究（STEP UP）：一项随机、对照、IIIb期临床试验
errThe Lancet Diabetes & Endocrinology
IF0
err2025-09-14
err0
PREAI
errSean Wharton; Paula Freitas; Jøran Hjelmesæth; Maria Kabisch; Kristian Kandler; Ildiko Lingvay; Maria Quiroga; Julio Rosenstock; W Timothy Garvey
err分享
err收藏
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial每周一次司美格鲁肽7.2 mg在肥胖和2型糖尿病成人中的疗效研究（STEP UP T2D）：一项随机、对照、3b期临床试验
errThe Lancet Diabetes & Endocrinology
IF0
err2025-09-14
err0
PREAI
errIldiko Lingvay; Sara J Bergenheim; John B Buse; Paula Freitas; W Timothy Garvey; Nina M Harder-Lauridsen; Julio Rosenstock; Kushal Sahu; Sean Wharton
err分享
err收藏
Use of commercially available automated insulin delivery systems in pregnant people with type 1 diabetes商业性自动胰岛素输送系统在1型糖尿病孕妇中的应用
errDiabetes Research and Clinical Practice
IF7.4
err2025-09-01
err0
PREAI
errAngela Q. Pham; Ildiko Lingvay; Nicole Ahmadi; Patricia C. Santiago-Munoz; Marconi Abreu
err分享
err收藏
Adherence to app-based dose guidance for once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5应用基于应用程序的剂量指导对胰岛素初治的2型糖尿病患者每周一次胰岛素icodec的依从性：ONWARDS 5的事后分析
errdiabetes obesity metabolism
IF0
err2025-08-13
err0
PREAI
errHarpreet S. Bajaj MD; Lars Villads Bennedsen MD; Anders Meller Donatsky MD; Johannes Handberg Juul Martiny PhD; André Vianna MD; Ildiko Lingvay MD
err分享
err收藏
Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management每周一次胰岛素icodec的临床应用：将临床试验数据转化为糖尿病管理的实用指南
errDrugs
IF14.4
err2025-08-13
err0
errOAAI
errAthena Philis-Tsimikas; Jens Aberle; Harpreet Bajaj; Ildiko Lingvay; Yiming Mu; Shehla Shaikh; André Vianna; Hirotaka Watada; Stefano Del Prato
err分享
err收藏
Association of GLP1-receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetesGLP1受体激动剂使用与肝脂肪变性伴糖尿病患者肝脏疾病进展、主要心血管事件及死亡的关系
errdiabetes obesity metabolism
IF0
err2025-07-30
err0
PREAI
errSuleiman Al Ashi MD; Raj Shah MD; Nofel Iftikhar BA; Ildiko Lingvay MD; Mustafa Kinaan MD; Ishak A. Mansi MD
err分享
err收藏
Author's response to the Letter to the Editor “Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy”作者对编辑信件的回应 “Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy”
errJournal of Diabetes and its Complications
IF3.1
err2025-07-25
err0
PREAI
errShubham Agarwal; F.N.U. Sidra; Ildiko Lingvay
err分享
err收藏
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-Diabetes trial美国心脏病诊所开具SGLT-2i和/或GLP-1RA处方的患者特征：来自COORDINATE-Diabetes试验的见解
errAmerican Journal of Preventive Cardiology
IF5.9
err2025-07-23
err0
errOAAI
errAdam J Nelson; Lisa A. Kaltenbach; Hussein R. Al-Khalidi; Monica Leyva; Laura Webb; Darren K. McGuire; Rodica Pop-Busui; Matthew A Cavender; Vanita R. Aroda; Melissa L. Magwire; Caroline R. Richardson; Ildiko Lingvay; Julienne K. Kirk; Ambarish Pandey; Tanya Gaynor; Jonathan Pak; Alana Washington; Cagri Senyucel; Renato D. Lopes; Jennifer B. Green; Christopher B. Granger; Neha J Pagidipati
err分享
err收藏
International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity国际肥胖外科协会关于临床肥胖中药物治疗后代谢减重手术的声明
errThe Lancet Diabetes & Endocrinology
IF0
err2025-07-22
err0
PREAI
errRicardo V Cohen; Gerhard Prager; Carel W le Roux; Ildiko Lingvay; Paulina Salminen
err分享
err收藏
Body Mass Index, Central Adiposity, and HFpEF体重指数、中心性肥胖和HFpEF
errJournal of the American College of Cardiology
IF22.3
err2025-07-21
err0
PREAI
errKlara R. Klein; Jaime P. Almandoz; Darren K. McGuire; Ildiko Lingvay
err分享
err收藏
Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1tirzepatide治疗组参与者早期体重下降反应随时间的体重减轻：SURMOUNT-1的事后分析
errdiabetes obesity metabolism
IF0
err2025-07-17
err0
errOAAI
errJamy Ard MD; Clare J. Lee MD; Kimberly Gudzune MD; Brandi Addison DO; Ildiko Lingvay MD; Dachuang Cao PhD; Casey J. Mast PharmD; Adam Stefanski MD; Beverly Falcon PhD; Donna Mojdami MD
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
A
Arun J. Sanyal
H 指数: 166 · 论文数: 1.4K
K
Kamlesh Khunti
H 指数: 162 · 论文数: 2.1K
C
Christopher B. Granger
H 指数: 155 · 论文数: 1.4K
T
Takashi Kadowaki
H 指数: 153 · 论文数: 1.4K
J
John A. Spertus
H 指数: 151 · 论文数: 2.0K
查看更多